Results 131 to 140 of about 648 (164)
Some of the next articles are maybe not open access.
Opioid-sparing Effects of the Nrf2 Activator Diroximel Fumarate in Mice
The Journal of Pain, 2022Mohd Sami Ur Rasheed +2 more
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Abstract Diroximel fumarate, sold under the brand name Vumerity, is a medication used for the treatment of relapsing forms of multiple sclerosis (MS). It acts as an immunosuppressant and anti-inflammatory drug. Diroximel fumarate is hypothesized to regulate cell signalling pathways, causing beneficial immune and neuroprotective effects.
Mohammad Atika Afreen Shafi +3 more
openaire +1 more source
Mohammad Atika Afreen Shafi +3 more
openaire +1 more source
Association of British Neurologists: Annual Meeting Abstracts 2023, 2023
Houtchens Maria +9 more
openaire +1 more source
Houtchens Maria +9 more
openaire +1 more source
DIROXIMEL FUMARATE REDUCES ATHEROSCLEROTIC PLAQUE SIZE AND INSTABILITY
AtherosclerosisV. Nankivell +10 more
openaire +1 more source
Adverse events analysis of Diroximel fumarate based on FAERS database
Journal of the Neurological SciencesPeipei, Luan +5 more
openaire +2 more sources

